TY - JOUR
T1 - Alternative vaccination locations
T2 - Who uses them and can they increase flu vaccination rates?
AU - Lee, Bruce Y.
AU - Mehrotra, Ateev
AU - Burns, Rachel M.
AU - Harris, Katherine M.
N1 - Funding Information:
The survey data was collected under a contract with GlaxoSmithKline. Investigator time was supported by the National Institute General Medical Sciences Models of Infectious Agent Study (MIDAS) through grant U01-GM070708-05.
PY - 2009/7/9
Y1 - 2009/7/9
N2 - Since many unvaccinated individuals do not regularly contact the traditional health care system, we sought to determine the role that alternative vaccination locations (e.g., workplaces and retail clinics) could play in increasing influenza vaccination coverage. Between February 14, 2008 and March 10, 2008, a 25-question influenza vaccine questionnaire was administered to a nationally representative, stratified sample of panelists. Our results found that while alternative locations are covering some segments not captured by the traditional health care system (e.g., younger, working, white individuals in metropolitan areas), they are not serving many other segments (e.g., minority, rural, or lower income patients).
AB - Since many unvaccinated individuals do not regularly contact the traditional health care system, we sought to determine the role that alternative vaccination locations (e.g., workplaces and retail clinics) could play in increasing influenza vaccination coverage. Between February 14, 2008 and March 10, 2008, a 25-question influenza vaccine questionnaire was administered to a nationally representative, stratified sample of panelists. Our results found that while alternative locations are covering some segments not captured by the traditional health care system (e.g., younger, working, white individuals in metropolitan areas), they are not serving many other segments (e.g., minority, rural, or lower income patients).
KW - Influenza vaccine
KW - Retail clinics
KW - Vaccination location
KW - Workplaces
UR - http://www.scopus.com/inward/record.url?scp=67649484352&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67649484352&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2009.04.055
DO - 10.1016/j.vaccine.2009.04.055
M3 - Article
C2 - 19406181
AN - SCOPUS:67649484352
SN - 0264-410X
VL - 27
SP - 4252
EP - 4256
JO - Vaccine
JF - Vaccine
IS - 32
ER -